- Home
- CMMB vs INTG Comparison
CMMB vs INTG Comparison
Compare CMMB & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- INTG
- Stock Information
- Founded
- CMMB 2004
- INTG 1965
- Country
- CMMB Israel
- INTG United States
- Employees
- CMMB N/A
- INTG N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- INTG Building operators
- Sector
- CMMB Health Care
- INTG Real Estate
- Exchange
- CMMB Nasdaq
- INTG Nasdaq
- Market Cap
- CMMB 22.0M
- INTG 24.0M
- IPO Year
- CMMB N/A
- INTG N/A
- Fundamental
- Price
- CMMB $0.95
- INTG $11.57
- Analyst Decision
- CMMB Strong Buy
- INTG
- Analyst Count
- CMMB 2
- INTG 0
- Target Price
- CMMB $8.50
- INTG N/A
- AVG Volume (30 Days)
- CMMB 125.0K
- INTG 3.2K
- Earning Date
- CMMB 08-20-2025
- INTG 09-29-2025
- Dividend Yield
- CMMB N/A
- INTG N/A
- EPS Growth
- CMMB N/A
- INTG N/A
- EPS
- CMMB N/A
- INTG N/A
- Revenue
- CMMB N/A
- INTG $61,597,000.00
- Revenue This Year
- CMMB N/A
- INTG N/A
- Revenue Next Year
- CMMB N/A
- INTG N/A
- P/E Ratio
- CMMB N/A
- INTG N/A
- Revenue Growth
- CMMB N/A
- INTG 6.76
- 52 Week Low
- CMMB $0.87
- INTG $9.57
- 52 Week High
- CMMB $2.55
- INTG $19.24
- Technical
- Relative Strength Index (RSI)
- CMMB 17.79
- INTG 50.73
- Support Level
- CMMB $0.87
- INTG $10.81
- Resistance Level
- CMMB $1.01
- INTG $12.38
- Average True Range (ATR)
- CMMB 0.06
- INTG 0.64
- MACD
- CMMB -0.01
- INTG 0.12
- Stochastic Oscillator
- CMMB 23.78
- INTG 60.06
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About INTG Intergroup Corporation (The)
The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.